Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare
Summary
Generative artificial intelligence (AI) faces many growing pains as it seeks its footing. In a recent survey, management consulting firm Bain & Company reveals that the main barriers to generative AI in healthcare are a lack of resources, expertise and regulation, with data access and quality and organizational resistance close behind. The recurring theme across industry studies is that generative AI in healthcare is nascent and needs time to prove its efficacy and to earn public trust. Robust benchmarks will increase confidence. The lesson for technology companies, pharmaceutical firms and healthcare providers considering generative AI in their strategies is that the technology is not yet fully optimized for healthcare. For generative AI to bear fruit, it needs investors, technology, resources, expertise, LLMs trained with healthcare-specific data, and robust guidelines. Ultimately, society needs to be ready for and comfortable with the involvement of generative AI in managing patient health and treatment. The task ahead entails expanding resources and expertise, training models on healthcare-specific data and establishing robust benchmarks. In time, through multiple iterations, generative AI will sharpen its analysis. Developers will fine-tune the benchmarks and criteria used in their models, aligning them with emerging regulatory guidelines. The result will be improved accuracy in diagnoses and recommended treatments. Ethical guidelines and human readiness will shape generative AI use and governance. Regulators are urged to move fast, but doing so too quickly could bring unintended consequences. The same caution applies to technology companies that are eager to earn a profit from their innovations. AI tools that gain FDA approval are setting a precedent for what will become commonplace in the future. The potential downside may be that ethical dilemmas will prompt companies and regulators to reconsider their positions. According to a recent study, Americans have mixed feelings about the use of generative AI in their healthcare. While they are enthusiastic about the potential benefits, most Americans are hesitant to replace their medical professionals with this technology. These sentiments may shift over time as technology matures and regulatory guidelines become more robust.The post Generative AI’s Technology Is Not Yet Fully Optimized for Healthcare first appeared on PYMNTS.com.
In "This Is How They Tell Me the World Ends," Nicole Perlroth, a former New York Times reporter, offers a detailed picture of how the zero-day exploit tra…
In "This Is How They Tell Me the World Ends," Nicole Perlroth, a former New York Times reporter, offers a detailed picture of how the zero-day exploit trade developed and affects critical infrastructure.
The post First Bitcoin ETF, Now Ethereum ETF, Whose Next SOL, XRP? appeared first on Coinpedia Fintech News On January 11, the U.S. Securities and Exchang…
First Bitcoin ETF, Now Ethereum ETF, Whose Next SOL, XRP?
Digital Currencies · Blockchain · Banking Infrastructure
Summary
The post First Bitcoin ETF, Now Ethereum ETF, Whose Next SOL, XRP? appeared first on Coinpedia Fintech News On January 11, the U.S. Securities and Exchange Commission (SEC) approved the first Spot Bitcoin ETF. Four months later, the SEC approved another spot ETF, this time for Ethereum. This highlights the SEC’s evolving stance toward crypto adoption. Meanwhile, Crypto analysts at Standard Chartered weighed in on the potential ETF launch for other altcoins. Solana & XRP ETFs On The Line With Ethereum ETFs now on the market, attention is shifting towards other potential candidates for ETF approval. Geoffrey Kendrick, Head of Forex and Digital Assets Research at Standard Chartered Bank, suggests that Solana (SOL) and XRP ETFs could be approved as early as 2025. JUST IN: Standard Chartered analyst Geoffrey Kendrick said that cryptocurrency ETFs such as SOL and XRP may be approved in 2025, and the approval of the ETH ETF means that ETH and similar cryptocurrencies will not be classified as securities. pic.twitter.com/RECYwTnVRr— SolanaFloor (@SolanaFloor) May 24, 2024 Kendrick further highlights that the SEC’s treatment of Ethereum could set a precedent for other cryptocurrencies. He points out that if Ethereum is not considered a security, other coins with similar characteristics, such as Solana and XRP, might also evade this classification. Kendrick notes that the recent approval of Ethereum ETFs implies that ETH-like coins, which share similar technological foundations, may not be classified as securities by the SEC. The Future of Crypto ETFs Crypto analyst The Birb Nest observes that the narrative around a Solana ETF is gaining momentum on crypto Twitter and among media outlets. He suggests that while regulation will take time, the anticipation of a Solana ETF is growing. In the meantime, market participants are encouraged to drive a “full-blown meme mania” around Solana, similar to the hype seen with meme tokens like Dogecoin (DOGE) and Shiba Inu (SHIB). They will try to push the narrative that $SOL is another ETF.This will probably happen, but they definitely need more time and they need to introduce a legitimate #crypto regulatory framework.It will take time, but before they do that in the meantime we can unleash a… https://t.co/kHDZ1SMTwx— THE ₿IRB NEST (@TheBirbNest) May 24, 2024 BTC+ETH dominance will rise’ However, Kendrick predicts that Bitcoin and Ethereum will continue to dominate the market. He expects a strong inflow of investments into spot Bitcoin ETFs, projecting a potential BTC price target of $150,000 by the end of the year. This expected increase in Bitcoin and Ethereum dominance suggests that they will remain key players in the evolving landscape of cryptocurrency ETFs. As the SEC continues to pave the way for more crypto ETFs, the future looks promising for digital assets like Solana and XRP.
The post Ondo Hits New Highs Above $1; Will the Price Cross the Final Barrier to Reach $1.5? appeared first on Coinpedia Fintech News Bullish clouds are h…
Ondo Hits New Highs Above $1; Will the Price Cross the Final Barrier to Reach $1.5?
Digital Currencies
Summary
The post Ondo Hits New Highs Above $1; Will the Price Cross the Final Barrier to Reach $1.5? appeared first on Coinpedia Fintech News Bullish clouds are hovering over the crypto space as traders have become optimistic, followed by the approval of the spot Ethereum ETF. The traders became more sure of the next price action when the ETH price surged magnificently but fell short of a few dollars in reaching $4000. In the meantime, some altcoins have been maintaining a steep upswing while some are recording new ATH like Ondo, which has surged over 15% in the past 24 hours. After such a massive rally, many may expect a bearish pullback, but from a larger perspective, the token appears to be preparing for a fresh upswing, targeting another 40% upswing. The SEC approving the spot ETH ETF has catalysed the ongoing bullish upswing which has also led to the speculations of an altseason in a short while. ONDO price shot up by over 20% to reach $1.16 after consolidating below $1 for a few days. With this, the accumulated bullish momentum may assist a continued upswing for the rest of the month. As seen in the above chart, the ONDO price has been maintaining a strong bullish trend since the beginning. Meanwhile, the price is facing some hindrances in rising above the average bands of the rising parallel channel, but the bulls may lift the levels very soon. The RSI is in an incremental stage and may surge to reach within the overbought levels. This may offer the required push, but the price may refrain from reaching the upper resistance level of $1.5. Besides, the volume is also slowly piling up, which is offering the bulls the required momentum. Hence, the Ondo price is expected to maintain an elevated trend until the end of the month and discover new highs. Nevertheless, the price could rise and hit the upper resistance levels at $1.5 in the first few days of June, which will be a decisive phase for the token. If bulls hold their dominance, then a breakout could occur; otherwise, a rejection may cause the price to test lower support levels until it finds a strong base to trigger a rebound.